INTRODUCTION: The use of complementary and alternative medicine (CAM) among cancer survivors is high, yet less is known about reasons behind such use or the communication of CAM with conventional medical providers. METHODS: Cross-sectional, multivariate logistic regression models were developed to evaluate the similarities and differences between cancer survivors and non-cancer controls in the 2007 National Health Interview Survey with 23,393 participants, including 1,471 cancer survivors. RESULTS: Among cancer survivors, 66.5% reported ever using CAM and 43.3% having used CAM in the past year. When compared with the general population, cancer survivors used CAM more often for general disease prevention, immune enhancement, and for pain (Adjusted Odds Ratio [AOR] 1.27, 95% Confidence Interval [CI] 1.10-1.48; AOR 1.32, 95% CI 1.05-1.62; AOR 1.42, 95% CI 1.05-1.92, respectively). Cancer survivors were more likely to use CAM because of recommendations from their provider (AOR 1.54, 95% CI 1.26-1.88) and were more likely to disclose their CAM use to their provider (AOR 1.45, 95% CI 1.22-1.72). DISCUSSIONS/ CONCLUSIONS: When compared to the general population, cancer survivors were more likely to use CAM and communicate this use with providers, indicating a growing integration of CAM in conventional medical care. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors are more likely than the general population to communicate CAM use with providers, suggesting greater integration of CAM use in conventional care. However, the majority of CAM use is still not being communicated to providers, indicating an important area for improvement in patient-centered care.
INTRODUCTION: The use of complementary and alternative medicine (CAM) among cancer survivors is high, yet less is known about reasons behind such use or the communication of CAM with conventional medical providers. METHODS: Cross-sectional, multivariate logistic regression models were developed to evaluate the similarities and differences between cancer survivors and non-cancer controls in the 2007 National Health Interview Survey with 23,393 participants, including 1,471 cancer survivors. RESULTS: Among cancer survivors, 66.5% reported ever using CAM and 43.3% having used CAM in the past year. When compared with the general population, cancer survivors used CAM more often for general disease prevention, immune enhancement, and for pain (Adjusted Odds Ratio [AOR] 1.27, 95% Confidence Interval [CI] 1.10-1.48; AOR 1.32, 95% CI 1.05-1.62; AOR 1.42, 95% CI 1.05-1.92, respectively). Cancer survivors were more likely to use CAM because of recommendations from their provider (AOR 1.54, 95% CI 1.26-1.88) and were more likely to disclose their CAM use to their provider (AOR 1.45, 95% CI 1.22-1.72). DISCUSSIONS/ CONCLUSIONS: When compared to the general population, cancer survivors were more likely to use CAM and communicate this use with providers, indicating a growing integration of CAM in conventional medical care. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors are more likely than the general population to communicate CAM use with providers, suggesting greater integration of CAM use in conventional care. However, the majority of CAM use is still not being communicated to providers, indicating an important area for improvement in patient-centered care.
Authors: J S Carpenter; M A Andrykowski; P Sloan; L Cunningham; M J Cordova; J L Studts; P C McGrath; D Sloan; D E Kenady Journal: J Clin Epidemiol Date: 1998-12 Impact factor: 6.437
Authors: Jun J Mao; Steve C Palmer; Joseph B Straton; Peter F Cronholm; Shimrit Keddem; Kathryn Knott; Marjorie A Bowman; Frances K Barg Journal: J Cancer Surviv Date: 2008-04-15 Impact factor: 4.442
Authors: Suzanne C Danhauer; Elizabeth L Addington; Lorenzo Cohen; Stephanie J Sohl; Marieke Van Puymbroeck; Natalia K Albinati; S Nicole Culos-Reed Journal: Cancer Date: 2019-04-01 Impact factor: 6.860
Authors: Laura Weeks; Dugald Seely; Cathy DeGrasse; Shailendra Verma; Heather Boon; Marja Verhoef; Dawn Stacey Journal: Support Care Cancer Date: 2013-11-13 Impact factor: 3.603
Authors: Gabriel Lopez; Wenli Liu; Kevin Madden; Bryan Fellman; Yisheng Li; Eduardo Bruera Journal: Support Care Cancer Date: 2017-10-29 Impact factor: 3.603
Authors: Rashmi S Bismark; Hongbin Chen; Grace K Dy; Elizabeth A Gage-Bouchard; Martin C Mahoney Journal: Support Care Cancer Date: 2014-02-21 Impact factor: 3.603